Etravirine Tablet shortage
Etravirine Tablet is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Oct 2, 2026.
Janssen is permanently discontinuing its etravirine 100 mg tablets. The 100 mg and 200 mg strengths are still listed as available from other manufacturers, including Intelence (etravirine) 200 mg tablets from Janssen Products LP.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Etravirine Tablet. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Apr 28, 2026Currently in shortage2 of 2 products affected.
-
Apr 28, 2026First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Janssen Research and Development 📞 800-526-7736 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Intelence, Tablet, 100 mg (NDC 59676-570-01) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Etravirine, Tablet, 100 mg (NDC 10147-0570-1) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Etravirine Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Etravirine Tablet? options further down this page.
Why is Etravirine Tablet in shortage?
Janssen Research and Development has reported to the FDA that it is permanently stopping the manufacture of etravirine 100 mg tablets — this applies to both the generic version (NDC 10147-0570-1) and the brand-name Intelence (NDC 59676-570-01) in the 100 mg strength. So it's not a temporary supply hiccup or a factory delay — the company has made a decision to stop making this particular product for good.
It's worth noting that Janssen did not share a specific public reason why they made this decision — just that the discontinuation is happening. Also, this report only reflects what Janssen has filed with the FDA, so it speaks only to their products and not to what other manufacturers may or may not have available.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Etravirine Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Etravirine Tablet?
Etravirine tablets are currently on the FDA shortage list. If you take this medicine, I want to walk you through what this report means and what your next steps can be.
The strength affected here is the 100 mg tablet, and the manufacturer that filed this report (Janssen) has listed it as being discontinued, for both the Etravirine and Intelence versions. Because this is a discontinuation rather than a temporary delay, this particular supply problem may be permanent for that maker. There is no estimated-recovery date, since the company is stopping production.
Importantly, this report reflects only the manufacturer who filed it. The same medicine — etravirine — is still listed from other makers, including a 100 mg tablet from several companies. That matters for finding a steady supply.
Here is what I'd suggest, in order:
- Do not stop, skip, or change your doses on your own — staying on your HIV treatment without interruption is important.
- Ask your pharmacy to source the same medicine from another maker; a 100 mg etravirine tablet is available from AvKARE, Amneal, Leading Pharma, and Bionpharma, though it may not be in local stock.
- If your exact tablet cannot be found, ask your prescriber or pharmacist about options, such as using a different strength to reach your dose.
- Manufacturer contact numbers are listed on this page for reference; your pharmacy usually handles those calls.
This is general, national information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Etravirine Tablet?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Etravirine Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Etravirine | ETRAVIRINE 200 mg/1 | Tablet · Oral | Patriot Pharmaceuticals | 10147-0571-01 |
| Etravirine | ETRAVIRINE 100 mg/1 | Tablet · Oral | AvKARE | 42291-0473-12 |
| Etravirine | ETRAVIRINE 200 mg/1 | Tablet · Oral | AvKARE | 42291-0474-60 |
| Intelence | ETRAVIRINE 200 mg/1 | Tablet · Oral | Janssen Products LP | 59676-0571-01 |
| Intelence | ETRAVIRINE 25 mg/1 | Tablet · Oral | Janssen Products LP | 59676-0572-01 |
| Etravirine | ETRAVIRINE 100 mg/1 | Tablet · Oral | Amneal Pharmaceuticals NY LLC | 60219-1721-07 |
| Etravirine | ETRAVIRINE 200 mg/1 | Tablet · Oral | Amneal Pharmaceuticals NY LLC | 60219-1722-06 |
| Etravirine | ETRAVIRINE 100 mg/1 | Tablet · Oral | Leading Pharma, LLC | 69315-0285-20 |
| Etravirine | ETRAVIRINE 200 mg/1 | Tablet · Oral | Leading Pharma, LLC | 69315-0286-06 |
| Etravirine | ETRAVIRINE 100 mg/1 | Tablet · Oral | Bionpharma Inc. | 69452-0254-22 |
| Etravirine | ETRAVIRINE 200 mg/1 | Tablet · Oral | Bionpharma Inc. | 69452-0255-17 |
Therapeutic equivalents & pricing 7 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Etravirine 100 mg | Patriot | 120 tablets | $7.767 | AB | Availability likely |
| etravirine 100 mg | Amneal | 120 tablets | $7.767 | AB | Availability likely |
| Etravirine 100 mg | Leading | 120 tablets | $7.767 | AB | Availability likely |
| etravirine 100 mg | Bionpharma | 120 tablets | $7.767 | AB | Availability likely |
| etravirine 100 mg | AvKARE | 120 tablets | — | AB | FDA listed |
| Intelence 100 mg | Janssen | 120 tablets | — | AB | FDA listed |
| Etravirine 100 mg | Carnegie | 120 tablets | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Etravirine Tablet — that fall in the same broad treatment class (antivirals, hiv-specific, non-nucleoside, rti) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other antiviral shortages
Etravirine Tablet shortage FAQs
Is Etravirine Tablet in shortage?
Which products are affected?
When will Etravirine Tablet be available again?
Can I still get Etravirine somewhere?
What should I do if I take Etravirine Tablet?
Still have a question about the Etravirine Tablet shortage?
Ask a pharmacist about this shortage →View Etravirine Tablet on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.